GlycoNet is pleased to welcome André Vincent and Stephen Sampson to its Board of Directors. Their experience in governance, risk management, public policy, accounting, and the life sciences sector will strengthen the Board as GlycoNet continues to advance research, innovation, and commercialization in glycomics across Canada.

“André and Stephen bring valuable experience and perspective to GlycoNet’s Board,” said Louise St-Onge, Chair of GlycoNet’s Board of Directors. “Their insights will help us continue strengthening GlycoNet’s national role, supporting strong governance, and ensuring the network is well positioned for its next phase of growth and impact.”

André Vincent
André Vincent spent more than 25 years at Deloitte and held several leadership roles, including Chief Audit Operations Officer for Canada and Chief Security Officer and National Deputy Risk Management Leader.  He brings expertise in accounting, risk management, regulatory compliance, ethics, conflict of interest, confidentiality and privacy.

Stephen Sampson
Stephen Sampson is Senior Vice President at Global Public, responsible for Health and Life Sciences. He advises organizations on health policy, regulation, market access, and public affairs strategies. Previously, he was Director of Government Affairs at Canada’s Research-Based Pharmaceutical Companies, now known as Innovative Medicines Canada.